Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duloxetine for Fibromyalgia: Peripheral Tissue Innervation Study
NCT01619566Phase 4Withdrawn
- Sponsor
- University of California, San Diego
- Start
- Jun 2012
- Primary completion
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of duloxetine in fibromyalgia (FM), sponsored by University of California, San Diego. Primary endpoint: Pain Reduction at 12 weeks. Planned start Jun 2012; status: withdrawn.
02
Drugs
duloxetine
03
Conditions
fibromyalgia (FM)
Beyond the preview
Go deeper on NCT01619566.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01619566.